About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Fibromyalgia Market Analysis Report 2025-2035 | Market Expands on CNS Therapy Innovation, Rising Fibromyalgia Cases, Global Diagnosis Rates, and Telehealth Adoption - ResearchAndMarkets.com

The "Fibromyalgia Market - A Global and Regional Analysis: Focus on Treatment Type and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

Fibromyalgia is a complex chronic pain disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive dysfunction. Although its exact cause is unknown, it is believed to involve genetic, environmental, and psychological factors. The market includes medications such as antidepressants, anticonvulsants, and muscle relaxants, along with complementary therapies like cognitive behavioural therapy, exercise programs, and alternative medicine interventions.

The increasing development of novel drugs targeting central sensitization, coupled with rising investments in digital health tools and personalized medicine, is expanding treatment possibilities. Enhanced diagnostic criteria by organizations such as the American College of Rheumatology are contributing to better disease identification and management.

However, several challenges persist, such as underdiagnosis, social stigma, lack of definitive diagnostic tests, and limited efficacy of current treatments. However, ongoing research efforts, growing insurance coverage, and public education initiatives are anticipated to improve diagnosis rates and patient outcomes in the coming years.

Impact

Technological innovations in wearable health trackers, pain management applications, and digital therapeutics are transforming the fibromyalgia management landscape. Multi-disciplinary care approaches involving rheumatologists, neurologists, psychologists, and physiotherapists are increasingly being adopted to improve long-term health outcomes and quality of life for patients.

North America is projected to lead the fibromyalgia market due to advanced healthcare systems, high awareness levels, and the presence of key pharmaceutical players. Europe follows closely with active research initiatives and supportive reimbursement policies. Asia-Pacific shows robust growth potential fuelled by improving healthcare infrastructure and increased efforts in clinical diagnosis and chronic pain management.

How can this report add value to an organization?

Product/Innovation: This report provides comprehensive insights into the current trends in fibromyalgia, helping companies identify opportunities for drug and technology development. Organizations can leverage these insights to design therapies, medications, and platforms tailored to the needs of patients suffering from fibromyalgia, improving outcomes and enhancing market penetration.

Competitive: A detailed competitive landscape analysis helps organizations benchmark their market standing against key players. By understanding the strengths and weaknesses of competitors, companies can position themselves more effectively in the global fibromyalgia market.

Key Market Players and Competition Synopsis

The companies profiled in this report have been selected based on their market presence, product portfolio, and competitive positioning in the global fibromyalgia market.

Demand Drivers and Limitations

Demand Drivers for the Global Fibromyalgia Market:

  • Rising prevalence of chronic pain disorders and fibromyalgia
  • Development of targeted central nervous system therapies
  • Increasing awareness and diagnosis rates globally
  • Expansion of telehealth and mobile health solutions for pain management

Limitations for the Global Fibromyalgia Market:

  • Lack of curative therapies and limited treatment efficacy
  • Challenges in differential diagnosis and underreporting
  • Social stigma and misperception regarding fibromyalgia
  • High dependency on symptomatic management

Leading players in the global fibromyalgia market include:

  • Pfizer Inc.
  • AbbVie Inc.
  • Aurobindo Pharma
  • Dr. Reddy's Laboratories Ltd
  • Lupin
  • Tonix Pharmaceuticals Holding Corp
  • UCB Biopharma SRL
  • Scilex Holding
  • Tryptamine Therapeutics

Key Topics Covered:

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Fibromyalgia Market: Industry Analysis

1.1 Market Overview and Ecosystem

1.2 Epidemiological Analysis

1.3 Key Market Trends

1.3.1 Impact Analysis

1.4 Patent Analysis

1.4.1 Patent Filing Trend (by Country)

1.4.2 Patent Filing Trend (by Year)

1.5 Regulatory Landscape

1.6 Ongoing Clinical Trials

1.7 Market Dynamics

1.7.1 Overview

1.7.2 Market Drivers

1.7.3 Market Restraints

1.7.4 Market Opportunities

2. Global Fibromyalgia Market, by Treatment Type, $Million, 2023-2035

2.1 Pharmacological Interventions

2.1.1 Antidepressants

2.1.2 Anticonvulsant

2.1.3 Muscle Relaxants

2.1.4 Analgesics

2.1.5 Others

2.2 Non-Pharmacological Therapies

2.2.1 Physical Therapy

2.2.2 Occupational Therapy

3. Global Fibromyalgia Market, by Region, $Million, 2023-2035

3.1 North America

3.1.1 Market Dynamics

3.1.2 Market Sizing and Forecast

3.1.3 North America Fibromyalgia Market, by Country

3.1.3.1 U.S.

3.2 Europe

3.2.1 Market Dynamics

3.2.2 Market Sizing and Forecast

3.2.3 Europe Fibromyalgia Market, by Country

3.2.3.1 U.K.

3.2.3.2 France

3.2.3.3 Germany

3.2.3.4 Italy

3.2.3.5 Spain

3.3 Asia-Pacific

3.3.1 Market Dynamics

3.3.2 Market Sizing and Forecast

3.3.3 Asia-Pacific Fibromyalgia Market, by Country

3.3.3.1 Japan

4. Global Fibromyalgia Market, Competitive Landscape and Company Profiles

4.1 Competitive Landscape

4.1.1 Mergers and Acquisitions

4.1.2 Partnership, Alliances and Business Expansion

4.1.3 New Offerings

4.1.4 Regulatory Activities

4.1.5 Funding Activities

4.2 Company Profiles

4.2.1 Overview

4.2.2 Top Products / Product Portfolio

4.2.3 Top Competitors

4.2.4 Target Customers/End-Users

4.2.5 Key Personnel

4.2.6 Analyst View

For more information about this report visit https://www.researchandmarkets.com/r/b2bve0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.